INTRODUCTION
The specific dietary patterns of a population have a major influence on the prevalence and incidence of atherosclerotic vascular disease. This particularly manifests as the coronary heart disease (CHD) morbidity and mortality rates in various geographical regions. High consumption of saturated fats , cholesterol and energy are associated with higher blood cholesterol and higher frequency of myocardial infarction and death from CHD (1) . The discovery of the low density *Present address: Ashim Ghatak , Central Drug Research Institute, Lucknow, 226001, India.
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lipoprotein (LDL) receptor and the subsequent elucidation of its mode of action in the cell and in the body have provided a conceptual framework for understanding the mechanisms that control the concentration of the most abundant cholesterolcarrying lipoprotein in human blood (2). In tissue culture cells, the LDL receptor and the 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) are both subject to end-product feedback regulation by cholesterol.
When cellular cholesterol levels rise, the synthesis of HMG-CoA reductase and the synthesis of LDL receptors are suppressed. On the other hand, when cells have an increased demand for cholesterol, the production of LDL receptors and HMG-CoA reductase increases (3). The dietary cholesterol inhibits cholesterol synthesis mainly in the liver and small intestines and this inhibition contributes to maintainance of blood cholesterol at constant levels in healthy persons. Human trials and animal studies confirmed the relationship of dietary saturated fats and cholesterol intake to blood cholesterol and subsequently CHD.
Prevention of clinically manifested CHD and increase in healthful longevity are the long-term goals, but controlling other parameters such as blood plasma cholesterol, blood pressure and excess body weight, are very beneficial. Given the strong causal relationship with CHD, changes in these parameters in an individual or in a group of individuals, are quite acceptable endpoints of dietary therapy (4,5). It is possible that fatty acids and some other components express their effect at the level of the arterial wall to enhance the development of atherosclerosis. The possibility that certain dietary fats are uniquely atherogenic is intriguing, but to date their is no evidence to show that all dietary fats and oils are directly atherogenic independent of the effect on lipoprotein metabolism.
Although it has been generally believed that high intakes of fats raise the cholesterol level, a major nutritional discovery has been the finding that not all the components of dietary fats have the same effects on cholesterol levels (6). Dietary fat consists of triglycerides which contain fatty acids of three typessaturated (SFA), monounsaturated (MUFA) and polyunsaturated (PUFA), and each type of fatty acids appears to have different effects on cholesterol levels. In general, their effects on cholesterol levels are similar to those on LDL, but they can affect also other lipoproteins. Thus, each category of fatty acids should be considered separately.
Dietary Cholesterol
There is perhaps some confusion between the importance of the cholesterol content of the blood and that of the cholesterol content of the diet. The available evidence strongly suggests that, for most people, dietary cholesterol has much influence on blood cholesterol concentration (6, 7) . The CHD mortality and the serum cholesterol have been closely correlated with the SFA intake. The diet heart feasibility study in the 1960s also gave very useful information about changes in blood cholesterol when dietary SFA content was altered. Vegetarians eat virtually no cholesterol and enjoy considerably lower LDL cholesterol (LDL-C) than age-matched meat eaters (8) . There seems to be no requirement whatever for dietary cholesterol and the body synthesizes more than it needs each day .
Thus a very sensitive balance is maintained and any excess dietary intake leads to accumulation in the blood and subsequently deposition and atherosclerosis (9) (10) (11) . There is a consensus among epidemiologists that reduction of dietary cholesterol to below 300 mg/day induces a significant decline in the CHD risk for an individual. However, a more drastic restriction to approximately 200 mg/day total dietary cholesterol in moderate or high risk individuals can be extremely beneficial and may remarkably reduce CHD risk in these individuals (1,4,5). from the blood stream, but there is some evidence showing that LDL synthesis may also be reduced in some individuals (17, 18) . Since most LDL is normally removed from the plasma space by the liver through specific cell surface-receptor mechanisms (19) , the number or the rate of functioning of this receptor has been the subject of investigation. SFAS of less than 12 carbon units do not raise blood cholesterol (20) . Stearic acid (18:0) does not increase plasma LDL either in human or animal studies (21) . There is strong experimental evidence that this fatty acid is rapidly desaturated between the ninth and tenth carbons as counted from the terminal methyl carbon at the "omega" end of the molecule (22) . The product of this reaction is oleic acid (18:1 n-9), the most common monounsaturated fatty acid. Oleic acid has no significant effect in changing LDL-C (23). Saturated animal fats containing stearic acid would be expected to have less impact on LDL levels due to this effect. Populations around the Mediterranean, on Crete and Corfu take 10% or less of energy from SFAS and some Japanese in fishing villages consume even less (3 to 4% of energy intake), from this source.
PUFAs -They have two or more double bonds in their molecules. They are classified by the position of the first double-bounded carbon atom, at the third or sixth position from the terminal (omega) methyl group.
Thus, they are designated as n-3 or n-6 fatty acids. n-6 Fatty Acids -They are not synthesized in the body but play essential roles in cell structure and prostaglandins (24) . In general, the need is met if the intake is 1-2% of energy. However, the increasing consumption of linoleic acid (the predominant n-6 fatty acid) has raised this percentage to about 2 to 7% of total energy. There has been a considerably diverse opinion about the beneficial effects of increasing the intake of n-6 fatty acids over the years (24, 25 as it not only raises the LDL-C levels but also lowers HDL-C levels. The physical properties of TFAs are also very simialr to SFAs (40) . Thus care should be taken to avoid TFAs in diets as much as possible. Industry should be encouraged to point out on their labels the amount of TFA present in the hydrogenated oils and shortenings (40) . Maximum safe allowable limits are still being considered but it would be advisable to keep the total TFA intake below 10 g/day.
Epidemiological and Intervention Studies The earlier studies have conclusively proven that dietary modification can significantly reduce blood cholesterol which is the most important risk factor for the development of CHD (41, 42) . Most of these studies involve a reduction of SFAS and cholesterol and an increase in PUFAs or MUFAs. In most studies the morbidity from CHD declined significantly but the data were inconclusive as far as mortality was concerned (43) (44) (45) (46) (47) (48) . The large Multiple Risk Factor Intervention Trial (MRFIT) was designed to reduce the major risk factors in middle-aged men at high risk for CHD, high cholesterol, high blood pressure and excessive smoking. This study was carried out over a period of 6 years. The results indicated a significant reduction in risk factors in the intervention group with a minor reduction also in the control group (49) . The linkage of high intake of PUFAs especially n-3 type from marine fish sources and a lower mortality from cardiovascular disease among Greenland Eskimos as compared with the neighbouring Danes was highlitghed by pioneering studies by Dyerberg et al (50) .
The Eskimos were found to have significantly lower total cholesterol, LDL-C, VLDL-C and higher HDL-C than the Danish population. However, the major difference between the dietary fatty acid, n-3 and n-6, is the ability of the former to lower plasma triglycerides and VLDL in both normolipidemic and hyperlipidemic subjects. The reduction of VLDL levels by n-3 PUFAs is due to suppression of hepatic triglyceride and VLDL production. The n-3 PUFAs also induced a reduction of platelet aggregation by collagen and ADP, and also (unpublished data) all suggesting a decline of LDL-C without affecting the HDL-C fraction after ingesting olive oil-rich diet. Also, olive oil in experimental studies has shown marked reduction of oxidized (denatured) LDL which is highly atherogenic.
There was also reduction of end products of lipid peroxidation (58).
The Edinburgh-Stockholm study was the first formal study demonstrating a significantly lower proportion of adipose linoleic acid in a CHD. There was a significantly lower linoleic acid content in the adipose tissues of Edinburgh men compared with Stockholm men and on multivariate analysis, this turned out to be an independent risk factor (60,61). Similar results were shown by Oliver et al. (25) from North Karelia and Sapri (Calabria) (25) . The recent European report of an inverse correlation between adipose linoleic acid and CHD showed an indirect evidence that increased consumption is beneficial. The Oslo heart study also produced similar results. In a comparative study of linoleic, alpha-linoleic and marine fatty acids, it was found that linoleic acid was far superior for lowering LDL-C (62). A recently work was carried out in normal subjects to study the effect of dietary n-6 fatty acids on the incorporation of dietary n-3 fatty acids in serum and thrombocyte phospholipids. The results showed that incorporation of n-3 fatty acids in phospholipids was reduced by a high intake of n-6 fatty acids in the cells and lipid fraction studied (63). The observed effect of dietary n-6 fatty acids was independent of the energy percentage provided by dietary fat. In order to obtain an optimal effect of n-3 supplementation, the intake of linoleic acid has to be considered and kept on a low level. The cholesterol content of serum was unaffected, but the concentration of triacylglycerol was reduced during the supplementation period (63).
Conclusions
The reduction of dietary cholesterol to below 300 mg/day produces a significant decline in the CHD risk for an individual. However, a more drastic restriction to approximately 200 mg/day total dietary cholesterol in moderate or high risk individuals can be extremely beneficial and may remarkably reduce CHD risk in these individuals. Reduction of all saturated fats to below the 10% level (of total energy intake) is a practical and useful goal. A further reduction to 6-8% level in well-motivated patients would be highly beneficial in moderate and high-risk individuals. MUFAs (mainly oleic acid) can be consumed easily up to 10-15% of total energy intake as a routine and liberally even up to 20% without significant concern provided the total energy intake is well within limits to maintain desirable weight for that individual.
It is important to be aware of the TFA content in foods, oils and shortenings, but as yet no definite maximum limits have been set. n-6 PUFAs can be allowed up to about 7% of total energy intake.
There should be more studies of populations consuming higher levels of n-6
PUFAs to determine whether increased intake improves health or not in longterm trials. n-3 PUFAs, on the other hand, can be increased to 2-3% or even more with definite potential benefit. 
